Investigation Overview
July 16, 2013 (Shareholders Foundation) - An investigation on behalf of current long-term stockholders of shares of Imprimis Pharmaceuticals Inc (NASDAQ:IMMY) was announced concerning whether certain Imprimis Pharmaceuticals officers and directors possibly breached their fiduciary duties in connection with certain statements. The investigation by a law firm concerns whether certain I...
You must register (for free) or login to view the entire investigation.